Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TEV-56278 by Teva Pharmaceutical Industries for Solid Tumor: Likelihood of Approval
TEV-56278 is under clinical development by Teva Pharmaceutical Industries and currently in Phase I for Solid Tumor. According to GlobalData,...